Amjad Abouselo
Overview
Explore the profile of Amjad Abouselo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
10
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yousif M, Al-Natour M, Cavanagh R, Abouselo A, Apebende E, Ghaemmaghami A, et al.
ACS Macro Lett
. 2022 Oct;
11(10):1224.
PMID: 36201467
No abstract available.
2.
Al-Natour M, Yousif M, Cavanagh R, Abouselo A, Apebende E, Ghaemmaghami A, et al.
ACS Macro Lett
. 2022 Jun;
9(3):431-437.
PMID: 35648548
Poly(lactic--glycolic acid) (PLGA) is a versatile synthetic copolymer that is widely used in pharmaceutical applications. This is because it is well-tolerated in the body, and copolymers of varying physicochemical properties...
3.
Abouselo A, Rance G, Tres F, Taylor L, Kwokal A, Renou L, et al.
Mol Pharm
. 2021 Aug;
18(9):3247-3259.
PMID: 34399050
We have employed a bespoke setup combining confocal Raman microscopy and an ultraviolet-visible (UV-Vis) spectroscopy flow cell to investigate the effect of excipients on the disproportionation kinetics of Pioglitazone HCl...
4.
Martins C, Chauhan V, Araujo M, Abouselo A, Barrias C, Aylott J, et al.
Nanomedicine (Lond)
. 2020 Sep;
15(23):2287-2309.
PMID: 32945230
Therapeutic and diagnostic payloads are usually associated with properties that compromise their efficacy, such as poor aqueous solubility, short half-life, low bioavailability, nonspecific accumulation and diverse side effects. Nanotechnological solutions...